Pacific Biosciences of California Inc. announced that its HiFi whole-genome sequencing technology has been adopted as the first-line approach in a research effort to investigate Sudden Unexplained Death in Childhood (SUDC). The project, led by UW Medicine and Seattle Children’s researchers and supported by the SUDC Foundation, will use PacBio’s highly accurate long-read sequencing to analyze the genomes of affected children and their parents. The study aims to improve the detection of complex genetic variants and increase diagnostic yield, potentially offering families better answers about SUDC. The announcement did not specify if research results have already been presented, indicating that findings may be forthcoming.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pacific Biosciences of California Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9623718) on January 12, 2026, and is solely responsible for the information contained therein.